Caprock Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
VPM
VCM
Caprock Group's GH Position: Q1 2026 in Review
Caprock Group increased its Guardant Health (GH) stake by 7.1% in Q1 2026, buying an estimated $58.7K and bringing the position to 8,771 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #602.
Caprock Group first reported a position in GH in Q1 2025 and has held it in 4 quarters since. The position peaked at $836K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Caprock Group held 8,771 shares of Guardant Health worth $810K as of Q1 2026.
- Caprock Group bought 585 Guardant Health shares in Q1 2026, an estimated $58.7K.
- Guardant Health made up 0.02% of Caprock Group's portfolio in Q1 2026, its #602 holding.
- Caprock Group first reported a position in Guardant Health in Q1 2025 and has held it in 4 quarters since.
- Caprock Group's Guardant Health position peaked at $836K in Q4 2025.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.